Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103.
Times cited: 4
Randomized trial of lenalidomide alone versus lenalidomide plus rituximab in patients with recurrent follicular lymphoma: CALGB 50401 (Alliance).
Journal of Clinical Oncology.
Times cited: 38
A cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
Times cited: 97
Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas.
Leukemia and Lymphoma.
Times cited: 7